Terumo

#Terumo has published its Integrated Report for fiscal year 2023 ended March 31, 2024 (Terumo Report 2024) . The report includes ✅ The group's overall management policy ✅ Mid-to long-term growth strategies for the entire company ✅ Initiatives for creating social value through solving medical issues (CSV). ✅ Approach to sustainability management, key activity themes, promotion structure, ESG initiatives, and related data. For more information, please refer to the link provided. https://lnkd.in/g_Gdx8wD

Terumo Group’s commitment to advancing healthcare is reflected in our approach to Research & Development, with our R&D activities divided into two categories that drive innovation and business growth. #Corporate R&D focuses on long-term #research, developing new technologies and businesses that will shape the next decade. By collaborating with medical professionals and various stakeholders, we ensure our innovations align with real-world needs while strengthening our core technologies. #Company R&D, on the other hand, works on short- and medium-term product #development, enhancing our pipeline based on business strategies. With a Group-wide perspective, our Chief Technology Officer (CTO) drives synergy across regions, businesses, and organizations to maximize our impact. To see how our R&D activities are structured and how they support Terumo’s long-term vision, take a look at the slides.

#Terumo has announced its financial results for the third quarter of the fiscal year ending March 31, 2025 More information can be found here: https://lnkd.in/gRjTvkUM

More than just a symbol, the Terumo Group #Logo reflects our commitment to #healthcare, the dedication of every Associate to earning #trust in medical settings, and the drive to create new #value. Our mission, "Contributing to Society through Healthcare," is deeply embedded in our Logo.

Do you know when Terumo was founded? Take a quick moment to test your knowledge and discover more about the #history of our #company. Watch the video and find out if you can guess the right year! The answer is waiting inside.

We’re excited to launch Associate Interviews, a new series highlighting the experiences and insights of our Terumo Associates. In this first post, we’re featuring Hara, a team leader and Medical Sales Representative at our Tokyo branch. Hara leads #pharmaceutical and Medical Sales Representative activities across university hospitals. He shares his approach to building trust with #healthcare professionals, navigating the challenges of medical sales, and the rewards of providing value-driven #solutions. Hara’s approach to work? “I focus on #quality and substance rather than just numbers. Instead of rushing for quick results, I prioritize detailed, careful work, trusting that this approach naturally leads to success at crucial moments,” he explains. Read more about Hara’s work and experience in the slides, and stay tuned for more stories from our team in upcoming Team Interviews posts.

The Terumo Group is comprised of three companies, each uniquely focused on advancing healthcare and addressing critical medical needs worldwide. Operating in over 160 countries with a portfolio of 50,000+ products, through our three companies we aim to make treatments more effective, less burdensome, and safer for patients and medical professionals. 1. Cardiac and Vascular Company Specializes in minimally invasive solutions for vascular intervention and cardiac #surgery, offering devices to improve outcomes for conditions affecting the heart, brain, and blood vessels. 2. Medical Care Solutions Company (Terumo Medical Care Solutions) Focuses on providing advanced solutions that transform healthcare into a more caring and personalized experience, inspired by "yasashii"—a Japanese concept of #kindness. 3. Blood and Cell Technologies Company (Terumo Blood and Cell Technologies) Leads innovation in blood- and cell-based therapies, supporting efficient blood processing and the development of advanced treatments like #CellTherapy and #GeneTherapy. Learn more about how the Terumo Group is driving advancements in healthcare through its three companies: https://lnkd.in/gRMBtj3h

Since 1921, Terumo has upheld its Group Mission of “Contributing to Society through Healthcare”, a commitment reflected in the Terumo Group's Core Values that unite our Associates worldwide: #Respect – Appreciative of others #Integrity – Guided by our mission #Care – Empathetic to patients #Quality – Committed to excellence #Creativity – Striving for innovation These values drive us every day to create a better future for patients, healthcare providers, and society as a whole. Learn more about the Terumo Group's Mission and Core Values: https://lnkd.in/gzVQniuz

Happy New Year! FY2025 marks a significant milestone in our journey. As we step into the fourth year of our 5-Year #Growth Strategy, GS26, we are on track to achieve one of our major goals. This reflects our collective dedication to advancing #healthcare through #innovation, but also brings greater expectations and responsibilities. At Terumo, we remain united by our purpose: delivering life-saving products and services to where they are needed, when they are needed. As “One Terumo,” we will continue evolving our technologies and creating solutions that bring tangible benefits to patients and society, while upholding our commitments to #sustainability, DE&I, and community contributions. Here’s to a year of growth, innovation, and positive impact. Let’s make 2025 extraordinary together!

As we bid farewell to 2024, we want to express our heartfelt #gratitude to all of you for being an essential part of Terumo’s journey. This year has highlighted the incredible dedication of our associates and partners worldwide toward our #mission of “Contributing to Society through Healthcare.” As we look ahead to 2025, we envision a year filled with new #opportunities and continued growth—together with all of you. For now, we hope you have cherish moments with your loved ones. Wishing you a joyful holiday season and a prosperous new year! #ThankYou